Increasing insulin dose for olanzapine-related diabetes.
Johnson
Richard P
RP
Al-Taher
Mohammed T
MT
Madlock
Lawrence E
LE
Guo
Mei
M
Nasdahl
Clifford S
CS
D001569:Benzodiazepines; D001786:Blood Glucose / Q000378:metabolism; D015992:Body Mass Index; D016883:Diabetic Ketoacidosis / Q000097:blood / Q000139:chemically induced* / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D005500:Follow-Up Studies; D006801:Humans; D007328:Insulin / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D000077152:Olanzapine; D010890:Pirenzepine / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012016:Reference Values; D012559:Schizophrenia / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*
D001786:Blood Glucose; D007328:Insulin; D001569:Benzodiazepines; D010890:Pirenzepine; D000077152:Olanzapine